|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Food Frequency Questionnaire for Chinese Children Aged 12-17 Years: Validity and Reliability显示文摘Objective The primary objective of this study was to examine the validity and reliability of a semi-quantitative food frequency questionnaire(FFQ) among Chinese children aged 12-17 years. Methods A semi-quantitative 72-food item FFQ was developed for children aged 12-17 years. The reliability and validity of this FFQ were evaluated against 24-h dietary recalls(24 h DRs) to measure the consumption of foods and nutrients. We administered two FFQs and three DRs to children(N = 160) over a period of 1 month to evaluate the reliability and validity. Reliability was examined by quartile agreement and intraclass correlation coefficients(ICCs), and validity was examined by quartile agreement, Bland-Altman plots and correlation with DRs. Results For reliability, the ICCs between the two FFQs ranged from 0.21 to 0.76 for foods and nutrients, and the quartile agreement ranged from 70.0% to 95.0% in the same or adjacent quartiles. Spearman’s correlation coefficients of foods and nutrients between the second FFQ and the 24 h DRs ranged from-0.04 to 0.59. The Bland-Altman plots demonstrated good agreement across the range of intakes among nutrients. The quartile agreement ranged from 50.0% to 100.0%, with infrequent misclassification. Conclusion The FFQ assessment of dietary intakes demonstrated acceptable relative validity and high reproducibility for Chinese children aged 12-17 years. | LIU Dan JU La Hong YANG Zhen Yu ZHANG Qian GAO Jian Fen GONG Di Ping GUO Dan Dan LUO Shu Quan ZHAO Wen Hua | 2019 | Biomedical and Environmental Sciences2019，32，7： | 6 |
| 2 | Immunity:研究开发出最优的HIV疫苗递送模式显示文摘HIV已不再占据头条新闻。这主要是因为抗逆转录病毒药物的成功开发已将HIV病毒感染导致的艾滋病(AIDS)转化为一种慢性的可控制的疾病。然而。当前在全世界大约0.367亿名HIV感染者中,仅约一半的人能够获得控制这种病毒所需的药物。与此同时。新的HIV感染率持续保持在非常高的水平,这突出强调了需要开发一种预防性疫苗。然而,几十年来。 | Matthias Pauthner Colin Havenar-Daughton Devin Sok Joseph P. Nkolola Raiza Bastidas Archana V. Boopathy Diane G. Carnathan Abishek Chandrashekar Kimberly M. Cirelli Christopher A. Cottrell Alexey M. Eroshkin Javier Guenaga Kirti Kaushik Daniel W. Kulp Jinyan Liu Laura E. McCoy Aaron L. Oom Gabriel Ozorowski Kai W. Post Shailendra K. Sharma Jon M. Steichen Steven W. de Taeye Talar Tokatlian Alba Torrents de la Peña Salvatore T. Butera Celia C. LaBranche David C. Montefiori Guido Silvestri Ian A. Wilson Darrell J. Irvine Rogier W. Sanders William R. Schief Andrew B. Ward Richard T. Wyatt Dan H. Barouch Shane Crotty Dennis R. Burton | 2017 | 现代生物医学进展2017，17，27： | 2 |
| 3 | Treatment and prevention of hep- arin-induced thrombocytopenia:antithrombotic therapy and prevention of thrombosis, 9th ed:American College of Chest Physicians evidence- based clinical practice guidelines显示文摘 | Linkins LA Dans AL Moores LK | 2012 | Chest2012，，： | 1 |
| 4 | The nonsurglcal treatment burst fractures of the thoracolumbar junction显示文摘 | Reid DC Ho R Dans LA | 1988 | J Trauma1988，28，： | 1 |
| 5 | Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines显示文摘 | Linkins LA Dans AL Moores LK | 2012 | Chest2012，141，2： | 1 |
| 6 | Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines显示文摘 | Linkins LA Dans AL Moores LK | 2012 | Chest2012，141，2： | 1 |
| 7 | Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and preven- tion of thrombosis,9th ed: American College of Chest Physicians evi- dence-based clinical practice guidlines 显示文摘 | Linkins LA Dans AL Moores LK | 2012 | Chest2012，141，2： | 1 |
| 8 | IGF-I in epithelial ovarian cancer and its role in disease progression显示文摘 | Jane Brokaw Dionyssios Katsaros Andrew Wiley Lingeng Lu Dan Su Olga Sochirca Irene A. Rigault de la Longrais Susan Mayne Harvey Risch Herbert Yu | 2007 | Growth Factors2007，，5： | 1 |
| 9 | Treatment and prevention ofheparin-Induced thrombocytopenia: Antithrombotic Therapy and Pre-vention of Thrombosis,9th ed:American College of Chest PhysiciansEvidence-Based Clinical Practice Guidelines显示文摘 | Linkins LA Dans AL Moores LK | 2012 | Chest2012，141，2： | 1 |
| 10 | Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial显示文摘 | Claudio Ronco Rinaldo Bellomo Peter Homel Alessandra Brendolan Maurizio Dan Pasquale Piccinni Gluseppe La Greca | 2000 | The Lancet2000，，9223： | 1 |
| 11 | Treatment and preventionof heparin-induced thrombocytopenia : Antithrombotic Therapy andPrevention of Thrombosis, 9 th ed: American College of ChestPhysicians Evidence-Based Clinical Practice Guidelines 显示文摘 | Linkins LA Dans AL Moores LK | 2012 | Chest2012，141，2： | 1 |
| 12 | Fructosamineasa Complementary Fasting Blood Sug- ar Test for Glycemie Controlin Diabetic Patientson Hemodialysis显示文摘 | La dan Hosseini Gohari Farzaneh Moghadam Maryam Mah- di | 2011 | Laboratory Medicine2011，42，3： | 1 |
| 13 | Treatment and prevention of hepafin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines 显示文摘 | Linkins LA Dans AL Moores LK | 2012 | Chest2012，141，2： | 1 |
| 14 | Treatment and preven- tion of heparin-induced thrombocytopenia:antithrombotic therapy and prevention of thrombosis,9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines 显示文摘 | Linkins LA Dans AL Moores LK | 2012 | Chest2012，141，2： | 1 |
| 15 | Treatment and prevention of heparin-induced thromboeytopenia :antithrombotic therapy and prevention of thrombosis, 9th ed: Ameriean College of Chest Physicians evidenee-based clinical practice guidelines 显示文摘 | Linkins LA Dans AL Moores LK | 2012 | Chest2012，141，2： | 1 |
| 16 | Treatment and prevention of heparin-induced thrombocytopenia:Antithrombotic Therapy and Prevention of Thrombosis,9th ed:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines显示文摘 | Linkins LA Dans AL Moores LK | 2012 | Chest2012，141，2： | 1 |
| 17 | Treatment and preven- tion of heparin induced thrombocytopenia:Antithrombotic Thera- py and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence - Based Clinical Practice Guidelines 显示文摘 | Linkins LA Dans AL Moores LK | 2012 | Chest2012，141，2： | 1 |
| 18 | Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chestphysicians evidence-based clinical practice guidelines显示文摘 | Linkins LA Dans AL Moores LK | 2012 | Chest2012，141，： | 1 |
| 19 | Treatment and prevention of heparin-induced thromboeytopenia: Antithrombotic Therapy and Prevention of Thrombo- sis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines 显示文摘 | Linkins LA Dans AL Moores LK | 2012 | Chest2012，141，2： | 1 |
| 20 | Treatment and prevention of heparin-induced thrombocytopenia: AntithrornhotieTherapy and Prevention of Thrombosis, 9th ed: American College of ChestPhysicians Evidence-Based Clinical Praetiee Guidelines显示文摘 | Linkins LA Dans AL Moores LK | 2012 | Chest2012，141，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员